Exact Sciences (EXAS) Cash from Operations (2016 - 2025)
Historic Cash from Operations for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $151.7 million.
- Exact Sciences' Cash from Operations rose 22231.05% to $151.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $491.4 million, marking a year-over-year increase of 13342.23%. This contributed to the annual value of $491.4 million for FY2025, which is 13342.23% up from last year.
- Latest data reveals that Exact Sciences reported Cash from Operations of $151.7 million as of Q4 2025, which was up 22231.05% from $219.9 million recorded in Q3 2025.
- Over the past 5 years, Exact Sciences' Cash from Operations peaked at $219.9 million during Q3 2025, and registered a low of -$173.8 million during Q1 2022.
- Moreover, its 5-year median value for Cash from Operations was $35.6 million (2021), whereas its average is $26.6 million.
- As far as peak fluctuations go, Exact Sciences' Cash from Operations soared by 68714.7% in 2021, and later plummeted by 25101.77% in 2022.
- Exact Sciences' Cash from Operations (Quarter) stood at -$24.6 million in 2021, then skyrocketed by 311.77% to $52.0 million in 2022, then skyrocketed by 33.65% to $69.5 million in 2023, then tumbled by 32.33% to $47.1 million in 2024, then skyrocketed by 222.31% to $151.7 million in 2025.
- Its Cash from Operations stands at $151.7 million for Q4 2025, versus $219.9 million for Q3 2025 and $89.0 million for Q2 2025.